Skip to content

The Impact of Natural Cesarean Delivery on Peripartum Maternal Blood Loss.

The Impact of Natural Cesarean Delivery on Peripartum Maternal Blood Loss. A Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02768142
Enrollment
214
Registered
2016-05-11
Start date
2016-08-31
Completion date
2019-08-31
Last updated
2019-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage

Brief summary

Throughout the history, the neonate was dependent on maternal touch and care for survival. In modern obstetrics, with hospital care the neonates are seldom separated from their mothers after delivery. Early skin to skin (ESTS) contact after delivery was found to increase milk production, lactation and improve maternal and neonatal outcome. Oxytocin is the primary hormone responsible for uterine contraction and prevention of postpartum hemorrhage (PPH). ESTS contact increases oxytocin secretion. The rate of cesarean deliveries (CDs) increased dramatically over the past decades. CD was found to decrease postpartum milk production, postpones early lactation and decreases exclusive breastfeeding. During the typical CD, the neonate is usually presented for a short while to the mother and breastfeeding is usually delayed at least a number of hours until after the surgery and the recovery period. Natural CD, enable ESTS contact during the surgery and give the mother the opportunity to start breastfeeding immediately after delivery of the neonate in the surgery suit. Oxytocin secretion increases with ESTS and during breastfeeding. The aim of this study is to examine blood loss that occurs after Natural CD compared to standard CD without an ESTS contact.

Interventions

OTHERStandard cesarean delivery

Standard cesarean delivery

OTHERNatural cesarean delivery

Natural cesarean delivery

Sponsors

Raed Salim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
8 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Estimated to be appropriate for gestational age fetus. * Sonographic dating before 20 weeks of gestation.

Exclusion criteria

* Non-scheduled CD. * Major fetal malformations. * Multiple gestations. * Non-controlled diabetes. * Severe pre-eclampsia. * General anesthesia. * HIV carrier * Neonatal need for early resuscitation.

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin level after delivery4 daysDifference between pre- and post-surgical hemoglobin levels.

Secondary

MeasureTime frameDescription
Pain score during the operation1 hour
Pain score during the first day after cesarean delivery24 hoursUse of analgesic drugs
Analgesia use during the operation1 hourUse of analgesic drugs
Analgesia use during the first day after cesarean delivery24 hours
Blood product transfusion4 daysNumber of Packed red blood cells and plasma products
Rate of breastfeeding 6 months after delivery6 months
Maternal satisfaction of the delivery4 daysSatisfaction scale
Breast engorgement4 daysDiagnosed by physical examination
Neonatal temperature after delivery1 hourTemperature
Rate of breastfeeding at maternal hospital discharge4 days

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026